Skip to main content
. 2018 Jun 10;16(6):204. doi: 10.3390/md16060204

Figure 1.

Figure 1

Figure 1

Effect of heteronemin (A) on (B) cellular viability of human prostate cancer LNcap and PC3 cells in a dose-dependent manner for 24 h and (C) cellular growth of human prostate cancer LNcap cells in a time-dependent manner for 24, 48 and 72 h, respectively. Results are shown as mean ± SD (Standard Deviation) of three independent experiments. Data are expressed as mean ± SD. ** p < 0.01 or *** p < 0.001 vs solvent group.